Repeated cycles of binge-like ethanol (EtOH)-drinking in male C57BL/6J mice augments subsequent voluntary EtOH intake but not other dependence-like phenotypes
- PMID: 23647551
- PMCID: PMC3740058
- DOI: 10.1111/acer.12145
Repeated cycles of binge-like ethanol (EtOH)-drinking in male C57BL/6J mice augments subsequent voluntary EtOH intake but not other dependence-like phenotypes
Abstract
Background: Recently, procedures have been developed to model specific facets of human alcohol abuse disorders, including those that model excessive binge-like drinking (i.e., "drinking-in-the-dark," or DID procedures) and excessive dependence-like drinking (i.e., intermittent ethanol [EtOH] vapor exposure). Similar neuropeptide systems modulate excessive EtOH drinking stemming from both procedures, raising the possibility that both paradigms are actually modeling the same phenotypes and triggering the same central neuroplasticity. Therefore, the goal of this present project was to study the effects of a history of binge-like EtOH drinking, using DID procedures, on phenotypes that have previously been described with procedures to model dependence-like drinking.
Methods: Male C57BL/6J mice first experienced 0 to 10 four-day binge-like drinking episodes (3 days of rest between episodes). Beginning 24 hours after the final binge-like drinking session, mice were tested for anxiety-like behaviors (with elevated plus maze [EPM] and open-field locomotor activity tests), ataxia with the rotarod test, and sensitivity to handling-induced convulsions (HICs). One week later, mice began a 40-day 2-bottle (water vs. EtOH) voluntary consumption test with concentration ranging from 10 to 20% (v/v) EtOH.
Results: A prior history of binge-like EtOH drinking significantly increased subsequent voluntary EtOH consumption and preference, effects most robust in groups that initially experienced 6 or 10 binge-like drinking episodes and completely absent in mice that experienced 1 binge-like drinking episode. Conversely, a history of binge-like EtOH drinking did not influence anxiety-like behaviors, ataxia, or HICs.
Conclusions: Excessive EtOH drinking stemming from DID procedures does not initially induce phenotypes consistent with a dependence-like state. However, the subsequent increases in voluntary EtOH consumption and preference that become more robust following repeated episodes of binge-like EtOH drinking may reflect the early stages of EtOH dependence, suggesting that DID procedures may be ideal for studying the transition to EtOH dependence.
Keywords: Anxiety-Like; Ataxia; Binge-Like; C57BL/6J; Dependence; Ethanol; Seizure.
Copyright © 2013 by the Research Society on Alcoholism.
Figures

Similar articles
-
Alcohol Binge Drinking and Anxiety-Like Behavior in Socialized Versus Isolated C57BL/6J Mice.Alcohol Clin Exp Res. 2020 Jan;44(1):244-254. doi: 10.1111/acer.14236. Epub 2019 Dec 3. Alcohol Clin Exp Res. 2020. PMID: 31713874
-
Concomitant Caffeine Increases Binge Consumption of Ethanol in Adolescent and Adult Mice, But Produces Additive Motor Stimulation Only in Adolescent Animals.Alcohol Clin Exp Res. 2016 Jun;40(6):1351-60. doi: 10.1111/acer.13089. Epub 2016 May 7. Alcohol Clin Exp Res. 2016. PMID: 27154344 Free PMC article.
-
Bupropion, Alone and in Combination with Naltrexone, Blunts Binge-Like Ethanol Drinking and Intake Following Chronic Intermittent Access to Ethanol in Male C57BL/6J Mice.Alcohol Clin Exp Res. 2019 May;43(5):783-790. doi: 10.1111/acer.13992. Epub 2019 Mar 19. Alcohol Clin Exp Res. 2019. PMID: 30817015 Free PMC article.
-
"Drinking in the dark" (DID) procedures: a model of binge-like ethanol drinking in non-dependent mice.Alcohol. 2014 May;48(3):235-41. doi: 10.1016/j.alcohol.2013.08.005. Epub 2013 Oct 29. Alcohol. 2014. PMID: 24275142 Free PMC article. Review.
-
Intermittent ethanol access schedule in rats as a preclinical model of alcohol abuse.Alcohol. 2014 May;48(3):243-52. doi: 10.1016/j.alcohol.2014.01.006. Epub 2014 Mar 15. Alcohol. 2014. PMID: 24721195 Free PMC article. Review.
Cited by
-
Reduction of excessive alcohol drinking by a novel GABAB receptor positive allosteric modulator ADX71441 in mice.Psychopharmacology (Berl). 2014 Jan;231(2):333-43. doi: 10.1007/s00213-013-3245-z. Epub 2013 Aug 22. Psychopharmacology (Berl). 2014. PMID: 23975038 Free PMC article.
-
Long-term alcohol drinking in High Drinking in the Dark mice is stable for many months and does not show alcohol deprivation effects.Addict Biol. 2022 Jan;27(1):e13074. doi: 10.1111/adb.13074. Epub 2021 Jul 5. Addict Biol. 2022. PMID: 34227188 Free PMC article.
-
Environmental Enrichment Blunts Ethanol Consumption after Restraint Stress in C57BL/6 Mice.PLoS One. 2017 Jan 20;12(1):e0170317. doi: 10.1371/journal.pone.0170317. eCollection 2017. PLoS One. 2017. PMID: 28107511 Free PMC article.
-
IL-1 receptor signaling in the basolateral amygdala modulates binge-like ethanol consumption in male C57BL/6J mice.Brain Behav Immun. 2016 Jan;51:258-267. doi: 10.1016/j.bbi.2015.09.006. Epub 2015 Sep 10. Brain Behav Immun. 2016. PMID: 26365025 Free PMC article.
-
Affective Disruption During Forced Ethanol Abstinence in C57BL/6J and C57BL/6NJ Mice.Alcohol Clin Exp Res. 2020 Oct;44(10):2019-2030. doi: 10.1111/acer.14443. Epub 2020 Sep 20. Alcohol Clin Exp Res. 2020. PMID: 32862442 Free PMC article.
References
-
- Beadles-Bohling AS, Wiren KM. Anticonvulsive effects of kappa-opioid receptor modulation in an animal model of ethanol withdrawal. Genes Brain Behav. 2006;5:483–496. - PubMed
-
- Becker HC, Lopez MF. Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcohol Clin Exp Res. 2004;28:1829–1838. - PubMed
-
- Becker HC, Veatch LM. Effects of lorazepam treatment for multiple ethanol withdrawals in mice. Alcohol Clin Exp Res. 2002;26:371–380. - PubMed
-
- Choleris E, Thomas AW, Kavaliers M, Prato FS. A detailed ethological analysis of the mouse open field test: effects of diazepam, chlordiazepoxide and an extremely low frequency pulsed magnetic field. Neurosci Biobehav Rev. 2001;25:235–260. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- U01 AA020911/AA/NIAAA NIH HHS/United States
- K99 AA017668/AA/NIAAA NIH HHS/United States
- R37 AA013573/AA/NIAAA NIH HHS/United States
- AA020911/AA/NIAAA NIH HHS/United States
- T32 DA007244/DA/NIDA NIH HHS/United States
- AA017668/AA/NIAAA NIH HHS/United States
- AA013573/AA/NIAAA NIH HHS/United States
- R01 AA019454/AA/NIAAA NIH HHS/United States
- R01 AA015148/AA/NIAAA NIH HHS/United States
- AA015148/AA/NIAAA NIH HHS/United States
- AA019454/AA/NIAAA NIH HHS/United States
- P60 AA011605/AA/NIAAA NIH HHS/United States
- R00 AA017668/AA/NIAAA NIH HHS/United States
- R01 AA013573/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources